Business
Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO) - Daniella Yeheskely-Hayon PhD
RA'ANANA, Israel, Feb. 3, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira Technologies"), a
About this update from Qtrex Quantum Ltd.
[{"type":"text","content":"RA'ANANA, Israel, Feb. 3, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the \"Company\" or \"Inspira Technologies\"), a groundbreaking respiratory support technology company, announced today that Daniella Yeheskely-Hayon PhD, an expert in development of artificial lung, has been appointed as its Chief Technology Officer (CTO).\nThe position of CTO to which Yeheskely-Hayon was appointed, is a key position within the Company. As part of her role, Yeheskely-Hayon takes charge of the research and development (R&D) department relating to its oxygenators and sensors research including its In-vitro and In-vivo studies. \nYeheskely-Hayon holds a PhD in Biology from the \"Technion – The Israeli Institute of Technology\", which is among the world's top ten science and technology research Universities. Yeheskely-Hayon has an extensive academic work and significant peer-reviews publications with over than 18 publications she authored.\nYeheskely-Hayon has comprehensive project management experience in biomedical engineering as well as in key roles within medical device companies. Over the past six years, Yeheskely-Hayon has served as the director of research and development and Chief of Operations at O2Cure Ltd., an innovative medical device company that specializes in the development of long-term oxygenators and respiratory assist devices for hospitals.\nDaniella Yeheskely-Hayon Chief Technology Officer stated: \" I am delighted to join the Inspira Technologies' team and to work towards the Company's mission of becoming the new standard of care for acute respiratory patients. I believe my vast experience in the field of blood oxygenation and Extracorporeal Membrane Oxygenation (ECMO) devices will contribute to the development process of the Company's ART system.\"\nDagi Ben-Noon, Chief Executive Officer of Inspira Technologies, stated: \"It is a great honor to have Daniella Yeheskely-Hayon with us as our CTO. In the past year, Inspira Technologies has seen significant growth in its professional team. We believe that the advancement of human resources at Inspira Technologies is a key component to achieving the Company's goals as planned.\"\nAbout Inspira Technologies OXY B.H.N. Ltd.\nInspira Technologies is an innovative medical device company in the respiratory care industry. Inspira is developing the ART...